Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Frega

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Sciences|June 5, 2019
Microbiota: Overview and Implication in Immunotherapy-Based Cancer TreatmentsGiovanni Brandi, Giorgio Frega
Journal of Gastrointestinal Oncology|May 17, 2024
The emerging role of intra-tumoral bacteriaGiovanni Brandi, Giorgio Frega
The Lancet. Oncology|July 1, 2021
Second-line FOLFOX chemotherapy for advanced biliary tract cancerGiovanni Brandi, Giorgio Frega, Alessandro Rizzo
International Journal of Molecular Sciences|September 28, 2021
The Human Microbiomes in Pancreatic Cancer: Towards Evidence-Based Manipulation Strategies?Giovanni Brandi, Silvia Turroni, Florencia McAllister, et al.
Future Oncology (London, England)|January 17, 2019
Hypothyroidism in patients with hepatocellular carcinoma receiving cabozantinib: an unassessed issueVincenzo Di Nunno, Giorgio Frega, Lidia Gatto, et al.
Expert Review of Gastroenterology & Hepatology|March 31, 2021
FGFR inhibitors in elderly patients with advanced biliary tract cancer: an unsolved issueAlessandro Rizzo, Angela Dalia Ricci, Giorgio Frega, et al.
Journal of Clinical Medicine|December 17, 2024
Treatment Sequencing and Independent Outcomes of First- and Second-Line Chemotherapy in a Retrospective Series of Patients with Biliary Tract CancerGiorgio Frega, Andrea Palloni, Chiara Deiana, et al.
Oncoimmunology|September 16, 2020
Trial Watch: experimental TLR7/TLR8 agonists for oncological indicationsGiorgio Frega, Qi Wu, Julie Le Naour, et al.
Anti-Cancer Drugs|March 16, 2019
An astonishing case of liver-only metastatic colorectal cancer cured by FOLFOXIRI aloneAlessandro Rizzo, Andrea Palloni, Giorgio Frega, et al.
Expert Opinion on Investigational Drugs|November 21, 2020
Experimental HER2- targeted therapies for biliary tract cancerAlessandro Rizzo, Angela Dalia Ricci, Chiara Bonucci, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|June 5, 2019
Microbiota: Overview and Implication in Immunotherapy-Based Cancer TreatmentsGiovanni Brandi, Giorgio Frega
Journal of Gastrointestinal Oncology|May 17, 2024
The emerging role of intra-tumoral bacteriaGiovanni Brandi, Giorgio Frega
The Lancet. Oncology|July 1, 2021
Second-line FOLFOX chemotherapy for advanced biliary tract cancerGiovanni Brandi, Giorgio Frega, Alessandro Rizzo
International Journal of Molecular Sciences|September 28, 2021
The Human Microbiomes in Pancreatic Cancer: Towards Evidence-Based Manipulation Strategies?Giovanni Brandi, Silvia Turroni, Florencia McAllister, et al.
Future Oncology (London, England)|January 17, 2019
Hypothyroidism in patients with hepatocellular carcinoma receiving cabozantinib: an unassessed issueVincenzo Di Nunno, Giorgio Frega, Lidia Gatto, et al.
Expert Review of Gastroenterology & Hepatology|March 31, 2021
FGFR inhibitors in elderly patients with advanced biliary tract cancer: an unsolved issueAlessandro Rizzo, Angela Dalia Ricci, Giorgio Frega, et al.
Journal of Clinical Medicine|December 17, 2024
Treatment Sequencing and Independent Outcomes of First- and Second-Line Chemotherapy in a Retrospective Series of Patients with Biliary Tract CancerGiorgio Frega, Andrea Palloni, Chiara Deiana, et al.
Oncoimmunology|September 16, 2020
Trial Watch: experimental TLR7/TLR8 agonists for oncological indicationsGiorgio Frega, Qi Wu, Julie Le Naour, et al.
Anti-Cancer Drugs|March 16, 2019
An astonishing case of liver-only metastatic colorectal cancer cured by FOLFOXIRI aloneAlessandro Rizzo, Andrea Palloni, Giorgio Frega, et al.
Expert Opinion on Investigational Drugs|November 21, 2020
Experimental HER2- targeted therapies for biliary tract cancerAlessandro Rizzo, Angela Dalia Ricci, Chiara Bonucci, et al.
Pageof 6